Alamar Biosciences, Inc. (ALMR) vs Maravai LifeSciences Holdings, Inc. (MRVI)
A side-by-side comparison of Alamar Biosciences, Inc. and Maravai LifeSciences Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALMR
Alamar Biosciences, Inc.
$34.77HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
MRVI
Maravai LifeSciences Holdings, Inc.
$8.22HealthcareDelayed quote: Oct 6, 2026, 12:05 PM EDT
Total return — ALMR vs MRVI
growth of $100 · dividends reinvested · last 1yALMR +73.3% (+73.3%/yr)MRVI +149.9% (+149.9%/yr)MRVI compounded faster over this window
ALMR MRVI
ALMR vs MRVI: by the numbers
- •ALMR is the larger company ($2.41B vs $2.27B market cap).
- •Both run net losses; MRVI's is the smaller (-37.07% vs -40.18% net margin).
Metrics side by side
Valuation
| Metric | ALMR | MRVI |
|---|---|---|
| P/S ratio | N/A | 10.88 |
| P/B ratio | 7.70 | 11.10 |
| EV / EBITDA | N/A | 15.70 |
Profitability
| Metric | ALMR | MRVI |
|---|---|---|
| Gross margin | 56.20% | 17.98% |
| Operating margin | -42.22% | -3.63% |
| Net margin | -40.18% | -37.07% |
| ROE | N/A | -37.82% |
| ROIC | -26.95% | 16.96% |
Growth (annualized)
| Metric | ALMR | MRVI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -17.68% |
| Total return CAGR (5Y) | N/A | -27.63% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.